Document Detail


Late association of hyperparathyroidism in septic patients with multiple organ failure.
MedLine Citation:
PMID:  20116815     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Hypocalcemia after severe shock or sepsis stimulates release of parathyroid hormone (PTH), which abates with recovery. Sustained sepsis with multiple organ failure (MOF), however, may cause a resurgent release of PTH and life-threatening hypercalcemia. METHODS: Thirty critically ill patients with prolonged sepsis developed combined hypercalcemia with elevated serum PTH levels. The primary insult was trauma in 12 patients, peritonitis in 14, and pancreatitis in 4. MOF involved the lungs in 30 patients, kidney in 16, gut in 30, brain in 13, and a coagulopathy in 10. There were 12 deaths; hospital stay averaged 81 days. RESULTS: Hypercalcemia with increased serum levels of PTH occurred usually 3-4 weeks after the septic insult. Bradycardia, thought to be caused by the hypercalcemia, occurred in 19 patients, was attributed to a vasovagal reaction, and was treated with atropine. When asystole resulted, epinephrine and cardiopulmonary resuscitation were administered. Five patients required placement of an intravenous pacemaker. Bradycardia was acutely lethal in 4 patients; in a 5th patient, the decision was made for comfort care alone, and he died 9 days later. Bisphosphonate was given to 7 patients with this hypercalcemic-induced bradycardia and, prophylactically, to prevent bradycardia in 9 others. Hypercalcemia corrected in all patients; bradycardia abated in 7 patients. CONCLUSION: Hyperparathyroidism may occur with MOF secondary to sepsis. The mechanism is unclear, but the resultant bradycardia can be life threatening. Treatment with bisphosphonate corrects the hypercalcemia and bradycardia. Both the hypercalcemia and the bradycardia normalize when the MOF resolves.
Authors:
Charles E Lucas; Anna M Ledgerwood; Christopher C Jeffries; Patricia Vernier
Related Documents :
12915625 - The use in clinical practice of parathyroid hormone normative values established in vit...
2925155 - Vitamin e deficiency in primary biliary cirrhosis: gastrointestinal malabsorption, freq...
604625 - Tetracycline fluorescence in uremic and primary hyperparathyroid bone.
20858805 - High-intensity focused ultrasound to treat primary hyperparathyroidism: a feasibility s...
11547365 - Venous thromboembolic disease management patterns in total hip arthroplasty and total k...
16203675 - Clinical implication of hiatal hernia in patients with right isomerism.
Publication Detail:
Type:  Journal Article     Date:  2010-02-08
Journal Detail:
Title:  Surgery     Volume:  148     ISSN:  1532-7361     ISO Abbreviation:  Surgery     Publication Date:  2010 Jul 
Date Detail:
Created Date:  2010-06-15     Completed Date:  2010-07-01     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0417347     Medline TA:  Surgery     Country:  United States    
Other Details:
Languages:  eng     Pagination:  135-9     Citation Subset:  AIM; IM    
Copyright Information:
Copyright 2010 Mosby, Inc. All rights reserved.
Affiliation:
Department of Surgery, Wayne State University, Detroit, MI 48201, USA. clucas@med.wayne.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Bradycardia / etiology
Calcium / blood
Humans
Hypercalcemia / etiology
Hyperparathyroidism / blood,  etiology*
Multiple Organ Failure / complications*
Parathyroid Hormone / blood
Phosphorus / blood
Sepsis / complications*
Chemical
Reg. No./Substance:
0/Parathyroid Hormone; 7440-70-2/Calcium; 7723-14-0/Phosphorus

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Antiretroviral therapy for HIV prevention: many concerns and challenges, but are there ways forward ...
Next Document:  Postoperative Clostridium difficile-associated diarrhea.